...
首页> 外文期刊>Journal of Clinical Microbiology >Antibody reactivity to human and vervet cytomegalovirus early antigen(s) in sera from patients with active cytomegalovirus infections and from asymptomatic donors.
【24h】

Antibody reactivity to human and vervet cytomegalovirus early antigen(s) in sera from patients with active cytomegalovirus infections and from asymptomatic donors.

机译:患有活动性巨细胞病毒感染的患者和无症状供者对血清中人和vervet巨细胞病毒早期抗原的抗体反应性。

获取原文
           

摘要

Human fibroblasts were infected with vervet cytomegalovirus (VCMV) and cultured in medium containing 50 micrograms of cytosine arabinoside per ml for 72 h. Early antigens (EAg) were detected in the nuclei of infected cells by an indirect fluorescent antibody test with human sera having antibody to EAg of human cytomegalovirus (HCMV). Sera from patients with serological and/or virological evidence of active HCMV infection and from asymptomatic blood donors were examined for antibody activity with the HCMV and VCMV EAg's. The HCMV and VCMV EAg's were comparable in detecting levels of antibody activity and fluctuations in antibody titer of paired sera from patients. A total of 81% of patient sera reactive with HCMV EAg were also reactive with VCMV EAg. In contrast, only 14% of the asymptomatic donor sera reactive with HCMV EAg were also reactive with VCMV EAg. The VCMV EAg, therefore, appeared to differentiate latent from active infections in humans more effectively than did HCMV EAg.
机译:将人成纤维细胞用黑细胞巨细胞病毒(VCMV)感染,并在每毫升含50微克胞嘧啶阿拉伯糖苷的培养基中培养72小时。通过用具有抗人巨细胞病毒(HCMV)的EAg抗体的人血清的间接荧光抗体测试,在感染细胞的核中检测到早期抗原(EAg)。用HCMV和VCMV EAg检查具有活动性HCMV感染的血清学和/或病毒学证据的患者以及无症状献血者的血清的抗体活性。 HCMV和VCMV EAg在检测抗体活性水平和患者配对血清抗体滴度波动方面具有可比性。共有81%的患者血清与HCMV EAg反应,也与VCMV EAg反应。相反,仅14%的与HCMV EAg反应的无症状供体血清也与VCMV EAg反应。因此,VCMV EAg似乎比HCMV EAg更有效地将人的潜伏感染与主动感染区分开。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号